Arcus Capital Partners LLC Takes $678,000 Position in Cencora, Inc. $COR

Arcus Capital Partners LLC bought a new position in Cencora, Inc. (NYSE:COR) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,158 shares of the company’s stock, valued at approximately $678,000.

A number of other institutional investors have also recently bought and sold shares of COR. Kemnay Advisory Services Inc. acquired a new position in Cencora during the fourth quarter worth approximately $25,000. Oakworth Capital Inc. acquired a new position in shares of Cencora in the 4th quarter valued at $26,000. Elyxium Wealth LLC purchased a new stake in shares of Cencora during the 4th quarter valued at $27,000. Archer Investment Corp grew its stake in shares of Cencora by 134.3% during the 4th quarter. Archer Investment Corp now owns 82 shares of the company’s stock valued at $28,000 after buying an additional 47 shares during the period. Finally, Motiv8 Investments LLC acquired a new stake in Cencora during the 4th quarter worth approximately $29,000. 97.52% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, Director Lauren M. Tyler acquired 550 shares of Cencora stock in a transaction that occurred on Monday, June 22nd. The stock was acquired at an average price of $270.23 per share, with a total value of $148,626.50. Following the completion of the acquisition, the director directly owned 4,359 shares of the company’s stock, valued at $1,177,932.57. This trade represents a 14.44% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.38% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on COR shares. Evercore set a $360.00 price target on shares of Cencora in a research report on Wednesday, April 8th. William Blair assumed coverage on Cencora in a research note on Tuesday, April 28th. They issued a “market perform” rating for the company. Bank of America raised their target price on Cencora from $280.00 to $285.00 and gave the company a “neutral” rating in a report on Wednesday, June 24th. Weiss Ratings cut Cencora from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 30th. Finally, UBS Group increased their price objective on shares of Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a research report on Thursday, May 7th. Eleven equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, Cencora has an average rating of “Moderate Buy” and a consensus price target of $367.75.

Cencora Stock Performance

Shares of COR opened at $307.72 on Friday. Cencora, Inc. has a 1 year low of $244.82 and a 1 year high of $377.54. The company has a market cap of $59.87 billion, a price-to-earnings ratio of 23.60, a price-to-earnings-growth ratio of 1.71 and a beta of 0.58. The company has a debt-to-equity ratio of 3.40, a quick ratio of 0.59 and a current ratio of 0.95. The firm has a fifty day moving average of $279.98 and a 200-day moving average of $317.68.

Cencora (NYSE:COR) last posted its earnings results on Wednesday, May 6th. The company reported $4.75 EPS for the quarter, missing the consensus estimate of $4.82 by ($0.07). The business had revenue of $78.36 billion during the quarter, compared to analyst estimates of $81.09 billion. Cencora had a net margin of 0.78% and a return on equity of 135.20%. The firm’s revenue was up 3.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $4.42 earnings per share. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, equities analysts anticipate that Cencora, Inc. will post 17.79 earnings per share for the current year.

Cencora announced that its Board of Directors has approved a stock buyback program on Thursday, May 21st that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the company to buy up to 3.9% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s board of directors believes its shares are undervalued.

Cencora Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were paid a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date was Friday, May 15th. Cencora’s payout ratio is currently 18.40%.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.